Shree Ganesh Remedies Limited — Quarter and year ended March 31, 2026
| Sr No | Particulars | Details |
|---|---|---|
| 1 | Name | M/s. S N D K & Associates LLP, Chartered Accountants |
| 2 | Reason for change viz. appointment, re-appointment, resignation, removal, death or otherwise | Re-appointment of M/s. S N D K & Associates LLP, Chartered Accountants (Firm Registration No.: W100060) |
| 3 | Date of appointment / reappointment / cessation (as applicable) & term of appointment / re-appointment | Re-appointment is effective from May 14, 2026 |
| 4 | Term of Appointment | For the Financial Year 2026-2027. |
| 5 | Brief profile (in case of appointment) | M/s. S N D K & Associates LLP (Firm Registration No. W100060), is a LLP of Chartered Accountants. It has principal office at Navrangpura, Ahmedabad and is having more than 8 years of experience. It is primarily engaged in providing Auditing, Taxation & legal Consultancy and Finance Consultancy services to its clients. |
| 6 | Disclosure of Relationship between Directors (in case of appointment as a director) | Not Applicable |
| Particulars | Standalone (Audited) | Consolidation (Audited) | ||
|---|---|---|---|---|
| As at March 31, 2026 | As at March 31, 2025 | As at March 31, 2026 | As at March 31, 2025 | |
| ASSETS | ||||
| 1. Non-current Assets | ||||
| (a) Property, Plant and Equipment | 6,808.44 | 5,791.33 | 6,808.44 | 5,791.33 |
| (b) Capital Work-in-progress | 1,237.81 | 834.44 | 1,237.81 | 834.44 |
| (c) Right-of-use Assets | 3,654.51 | 3,705.49 | 3,654.51 | 3,705.49 |
| (d) Other Intangible Assets | 2.75 | 3.55 | 2.75 | 3.55 |
| (e) Intangible Assets under development | 48.54 | 43.42 | 48.54 | 43.42 |
| (f) Financial Assets | ||||
| (i) Investments | 16.30 | 16.30 | 8.00 | 8.00 |
| (ii) Other Financial Assets | 242.99 | 154.80 | 242.99 | 154.80 |
| (g) Other Non-current Assets | 179.44 | 895.50 | 179.44 | 895.50 |
| Total Non-current Assets | 12,190.78 | 11,444.83 | 12,182.48 | 11,436.53 |
| 2. Current Assets | ||||
| (a) Inventories | 2,400.52 | 2,201.79 | 2,400.52 | 2,201.79 |
| (b) Financial Assets | ||||
| (i) Investments | 1,245.39 | 1,825.83 | 1,245.39 | 1,825.83 |
| (ii) Trade Receivables | 3,256.50 | 2,226.98 | 3,256.50 | 2,226.98 |
| (iii) Cash and Cash Equivalents | 1,335.90 | 990.10 | 1,339.52 | 994.65 |
| (iv) Bank Balances other than (iii) above | 8.73 | 8.73 | 8.73 | 8.73 |
| (v) Other Financial Assets | 17.56 | 56.13 | 17.56 | 56.13 |
| (c) Other Current Assets | 318.24 | 409.25 | 318.24 | 409.25 |
| (d) Current Tax Assets (Net) | – | 34.14 | – | 34.14 |
| Total Current Assets | 8,582.84 | 7,752.95 | 8,586.46 | 7,757.50 |
| Total Assets | 20,773.62 | 19,197.78 | 20,768.94 | 19,194.03 |
| Particulars | Standalone (Audited) | Consolidation (Audited) | ||
|---|---|---|---|---|
| As at March 31, 2026 | As at March 31, 2025 | As at March 31, 2026 | As at March 31, 2025 | |
| EQUITY AND LIABILITIES | ||||
| 1. Equity | ||||
| (a) Equity Share Capital | 1,283.76 | 1,283.76 | 1,283.76 | 1,283.76 |
| (b) Other Equity | 15,017.78 | 13,235.51 | 15,013.10 | 13,231.76 |
| Total Equity | 16,301.54 | 14,519.27 | 16,296.86 | 14,515.52 |
| 2. Liabilities | ||||
| (A) Non-current Liabilities | ||||
| (a) Financial Liabilities | ||||
| (i) Borrowings | 2,124.77 | 2,948.23 | 2,124.77 | 2,948.23 |
| (ii) Lease Liabilities | 12.73 | 12.58 | 12.73 | 12.58 |
| (b) Provisions | 57.39 | 46.43 | 57.39 | 46.43 |
| (c) Deferred Tax Liabilities (Net) | 107.96 | 53.03 | 107.98 | 53.03 |
| Total Non-current Liabilities | 2,302.87 | 3,060.27 | 2,302.87 | 3,060.27 |
| (B) Current Liabilities | ||||
| (a) Financial Liabilities | ||||
| (i) Borrowings | 942.45 | 876.29 | 942.45 | 876.29 |
| (ii) Lease Liabilities | 1.34 | 1.34 | 1.34 | 1.34 |
| (iii) Trade Payables | ||||
| (a) Total outstanding dues of micro and small enterprises | 85.94 | 127.08 | 85.94 | 127.08 |
| (b) Total outstanding other than (ii) (a) above | 858.23 | 469.66 | 858.23 | 469.66 |
| (iv) Other Financial Liabilities | 200.38 | 124.47 | 200.38 | 124.47 |
| (b) Provisions | 3.51 | 2.67 | 3.51 | 2.67 |
| (c) Current Tax Liabilities (Net) | 55.59 | – | 55.59 | – |
| (d) Other Current Liabilities | 21.77 | 16.73 | 21.77 | 16.73 |
| Total Current Liabilities | 2,169.21 | 1,618.24 | 2,169.21 | 1,618.24 |
| Total Liabilities | 4,472.08 | 4,678.51 | 4,472.08 | 4,678.51 |
| TOTAL EQUITY AND LIABILITIES | 20,773.62 | 19,197.78 | 20,768.94 | 19,194.03 |
| Sr. No. | Particular | Quarter ended March 31, 2026 (Audited) | December 31, 2025 (Unaudited) | March 31, 2025 (Audited) | Year ended March 31, 2026 (Audited) | Year ended March 31, 2025 (Audited) |
|---|---|---|---|---|---|---|
| I | INCOME | |||||
| Revenue from Operations | 3,319.61 | 2,110.68 | 2,443.19 | 10,928.58 | 10,859.65 | |
| II | Other Income | 102.26 | 65.60 | 228.66 | 303.02 | 372.95 |
| III | Total Income (I+II) | 3,421.87 | 2,176.28 | 2,671.85 | 11,231.60 | 11,232.60 |
| IV | EXPENSES | |||||
| Cost of Materials Consumed | 1,103.34 | 894.67 | 951.40 | 4,091.90 | 3,738.11 | |
| Purchases of Stock-in-trade | – | – | – | – | 1.23 | |
| Changes in inventories of Finished Goods, Stock-in-trade and Work-in-progress | 319.01 | (261.37) | (367.03) | 95.69 | (151.99) | |
| Employee Benefit Expenses | 287.34 | 286.14 | 268.88 | 1,140.04 | 1,011.89 | |
| Finance Costs | 87.58 | 73.59 | 95.85 | 356.19 | 207.73 | |
| Depreciation and Amortisation expense | 279.82 | 266.73 | 242.45 | 1,047.30 | 956.69 | |
| Other Expenses | 472.48 | 518.25 | 602.17 | 2,098.99 | 2,339.21 | |
| Total Expenses (IV) | 2,549.57 | 1,778.01 | 1,793.73 | 8,830.11 | 8,102.87 | |
| V | Profit/(Loss) before Tax (III-IV) | 872.30 | 398.27 | 878.12 | 2,401.49 | 3,129.73 |
| VI | Tax Expense | |||||
| Current Tax | 147.35 | 161.80 | 226.47 | 564.83 | 804.68 | |
| Deferred Tax | 97.75 | (79.17) | (8.05) | 53.31 | (4.46) | |
| (Excess)/Short provision of tax of earlier years | – | 6.02 | 0.00 | 6.02 | 19.70 | |
| Total Tax Expense (VI) | 245.10 | 88.65 | 218.42 | 624.16 | 819.92 | |
| VII | Profit/(Loss) for the period after Tax (V-VI) | 627.20 | 309.62 | 659.70 | 1,777.33 | 2,309.81 |
| VIII | OTHER COMPREHENSIVE INCOME | |||||
| Items that will not be reclassified to profit or loss | ||||||
| Exchange Differences in translating the financial statements of foreign operations | – | – | – | – | – | |
| Remeasurement Gain/(Loss) on Defined Measurement Benefit Plans | 13.07 | (2.16) | 1.50 | 6.60 | (1.75) | |
| Income Tax Relating to above | (3.29) | 0.54 | (0.38) | (1.66) | 0.44 | |
| Total Other Comprehensive Income for the year (VIII) | 9.78 | (1.62) | 1.12 | 4.94 | (1.31) | |
| IX | Total Comprehensive Income for the year (VII+VIII) | 636.98 | 308.00 | 660.82 | 1,782.27 | 2,308.50 |
| X | Earning Per Share of ₹ 10 Par Value | |||||
| Paid-up Equity Share Capital (Face Value ₹ 10 each) | 1,283.76 | 1,283.76 | 1,283.76 | 1,283.76 | 1,283.76 | |
| Basic (In ₹ per share) | 4.88 | 2.41 | 5.13 | 13.84 | 17.98 | |
| Diluted (In ₹ per share) | 4.88 | 2.41 | 5.13 | 13.84 | 17.98 |
| Sr. No. | Particular | Quarter ended March 31, 2026 (Audited) | December 31, 2025 (Unaudited) | March 31, 2025 (Audited) | Year ended March 31, 2026 (Audited) | Year ended March 31, 2025 (Audited) |
|---|---|---|---|---|---|---|
| March 31, 2026 (Audited) | December 31, 2025 (Unaudited) | March 31, 2025 (Audited) | March 31, 2026 (Audited) | March 31, 2025 (Audited) | ||
| I | INCOME | |||||
| Revenue from Operations | 3,319.61 | 2,110.68 | 2,443.19 | 10,928.58 | 10,859.65 | |
| II | Other Income | 102.26 | 65.60 | 228.65 | 303.02 | 372.95 |
| III | Total Income (I + II) | 3,421.87 | 2,176.28 | 2,671.84 | 11,231.60 | 11,232.60 |
| IV | EXPENSES | |||||
| Cost of Materials Consumed | 1,103.34 | 894.67 | 951.41 | 4,091.90 | 3,738.11 | |
| Purchases of Stock-in-trade | – | – |